AMICUS THERAPEUTICS, INC. — Director's Dealing 2011

Jun 21, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2011-06-17

Reporting Person: Crowley John F (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-06-17	Common Stock	G	10000	$0.00	Disposed	79867	Direct
2011-06-17	Common Stock	P	20000	$6.04	Acquired	99867	Direct

Footnotes

F1: This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $5.94 to $6.21. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.